MSB 3.21% $1.13 mesoblast limited

Ann: 3 Articles on RYONCIL GvHD Trial Results Published in BBMT, page-125

  1. 4,194 Posts.
    lightbulb Created with Sketch. 5493
    I was going to say the same thing...... If we had 83% survive covid vs 90% mortality, back disc regeneration proof and all heart stem cell recipients surviving...... I would expect over 100 in the next 4 - 5 months.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.